Corrigendum: Bazi Bushen Capsule Alleviates Post-Menopausal Atherosclerosis via GPER1-Dependent Anti-Inflammatory and Anti-Apoptotic Effects

Corrigendum on: Huang D, Wang X, Zhu Y, Gong J, Liang J, Song Y, Zhang Y, Liu L and Wei C (2021) Bazi Bushen Capsule Alleviates Post-Menopausal Atherosclerosis via GPER1-Dependent Anti-Inflammatory and Anti-Apoptotic Effects. Front. Pharmacol. 12:658998. doi: 10.3389/fphar.2021.658998 Error in Figure/TableIn the original article, there was a mistake in Table 1 as published. BZBS is a post-marketing drug, and there is an error in the components of BZBS and ratio amounts in application. The corrected Table 1 appears below. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Abstract licence: CC BY

1 more reference, whose wording the paper’s licence keeps private.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.